Ixazomib Citrate With Gemcitabine Hydrochloride and Doxorubicin Hydrochloride in Treating Patients With Urothelial Cancer That is Metastatic or Cannot Be Removed by Surgery

Clinical trial NCT02420847 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT02420847
Sponsor: M.D. Anderson Cancer Center
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Metastatic Urothelial Carcinoma Transitional Cell Carcinoma Unresectable Transitional Cell Carcinoma

Start date: 2015-07-03
Primary completion: 2025-12-31
Enrollment: 57

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.